Evangelos Pazarentzos

The Hippo effector YAP promotes resistance to RAF- and MEK-targeted cancer therapies

Luping Lin, Amit J. Sabnis, Elton Chan et al. · Nature Genetics · 2015 · 553 citations · Full text

Medicine, Cancer Biology, Oncology +14

Fis1 and Bap31 bridge the mitochondria–ER interface to establish a platform for apoptosis induction

Ryota Iwasawa, Anne‐Laure Mahul‐Mellier, Christoph Datler et al. · The EMBO Journal · 2010 · 525 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +14

AXL Mediates Resistance to PI3Kα Inhibition by Activating the EGFR/PKC/mTOR Axis in Head and Neck and Esophageal Squamous Cell Carcinomas

Moshe Elkabets, Evangelos Pazarentzos, Dejan Juric et al. · Cancer Cell · 2015 · 340 citations · Full text

Medicine, Cancer Biology, Oncology +17

RAS-MAPK dependence underlies a rational polytherapy strategy in EML4-ALK–positive lung cancer

Gorjan Hrustanovic, Victor Olivas, Evangelos Pazarentzos et al. · Nature Medicine · 2015 · 277 citations · Full text

Medicine, Cancer Biology, Oncology +16

NF-κB-Activating Complex Engaged in Response to EGFR Oncogene Inhibition Drives Tumor Cell Survival and Residual Disease in Lung Cancer

Collin M. Blakely, Evangelos Pazarentzos, Victor Olivas et al. · Cell Reports · 2015 · 203 citations · Full text

Medicine, Cancer Biology, Oncology +15